BB Biotech as of Dec. 31, 2010
Portfolio Holdings for BB Biotech
BB Biotech holds 16 positions in its portfolio as reported in the December 2010 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 25.0 | $250M | 4.2M | 59.14 | |
| Gilead Sciences (GILD) | 19.9 | $200M | 5.5M | 36.24 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 17.5 | $176M | 5.0M | 35.03 | |
| Incyte Corporation (INCY) | 6.6 | $66M | 4.0M | 16.56 | |
| Micromet | 5.3 | $53M | 6.5M | 8.12 | |
| ImmunoGen | 3.6 | $36M | 3.9M | 9.26 | |
| Halozyme Therapeutics (HALO) | 3.2 | $32M | 4.0M | 7.92 | |
| Amylin Pharmaceuticals | 2.8 | $28M | 1.9M | 14.71 | |
| Amgen (AMGN) | 2.7 | $28M | 500k | 54.90 | |
| Alexion Pharmaceuticals | 2.6 | $26M | 325k | 80.55 | |
| BioMarin Pharmaceutical (BMRN) | 2.6 | $26M | 963k | 26.93 | |
| Optimer Pharmaceuticals | 2.3 | $23M | 2.0M | 11.31 | |
| Genzyme Corporation | 2.1 | $22M | 302k | 71.20 | |
| ISIS Pharmaceuticals | 1.8 | $18M | 1.8M | 10.12 | |
| Affymetrix | 1.0 | $10M | 2.0M | 5.03 | |
| Idenix Pharmaceuticals | 0.9 | $9.3M | 1.8M | 5.04 |
